F. Emmanuel

发表

Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice.

J. Caillaud, D. Branellec, J. Fruchart, 2000, Arteriosclerosis, thrombosis, and vascular biology.

Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits.

P. Denéfle, L. Houdebine, J. Caillaud, 1996, Circulation.

Atherosclerotic Lesions in Apolipoprotein E Adenovirus-Mediated Overexpression of Tissue Inhibitor of Metalloproteinase-1 Reduces

J. Caillaud, P. Horellou, P. Lesnik, 1999 .

Protection Against Atherogenesis in Mice Mediated by Human Apolipoprotein A-IV

P. Denéfle, J. Caillaud, J. Fruchart, 1996, Science.

Somatic gene transfer of human ApoA-I inhibits atherosclerosis progression in mouse models.

P. Denéfle, J. Caillaud, D. Branellec, 1999, Circulation.

Impairment of endothelium-dependent arterial relaxation by high-fat feeding in ApoE-deficient mice: toward normalization by human ApoA-I expression.

P. Gambert, G. Lizard, L. Lagrost, 1999, Circulation.

Endothelial derived vasorelaxation is impaired in human APO A-I transgenic rabbits.

P. Denéfle, J. Fruchart, G. Lebuffe, 1997, Biochemical and biophysical research communications.

Differential Interaction of the Human Cholesteryl Ester Transfer Protein with Plasma High Density Lipoproteins (HDLs) from Humans, Control Mice, and Transgenic Mice to Human HDL Apolipoproteins

L. Lagrost, D. Masson, D. Masson, 1997, The Journal of Biological Chemistry.

Transgenic rabbits expressing human apolipoprotein A-I in the liver.

P. Denéfle, B. Laine, J. Fruchart, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Interfacial Exclusion Pressure Determines the Ability of Apolipoprotein A-IV Truncation Mutants to Activate Cholesterol Ester Transfer Protein*

A. Tall, P. Denéfle, R. A. Anderson, 2002, The Journal of Biological Chemistry.

Apolipoprotein(a) Yeast Artificial Chromosome Transgenic Rabbits

E. Rubin, E. Gong, P. Denéfle, 1998, The Journal of Biological Chemistry.

Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient mice.

J. Caillaud, P. Horellou, P. Lesnik, 1999, Circulation.

Identification of specific amphipathic alpha-helical sequence of human apolipoprotein A-IV involved in lecithin:cholesterol acyltransferase activation.

R. Brasseur, S. Cuiné, M. Rosseneu, 1994, The Journal of biological chemistry.

Vascular Endothelial Growth Factor‐B Promotes In Vivo Angiogenesis

B. Lévy, D. Branellec, J. Silvestre, 2003, Circulation research.

High-level protein secretion into blood circulation after electric pulse-mediated gene transfer into skeletal muscle.

D. Scherman, A. Mahfoudi, F. Soubrier, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Structure and interfacial properties of chicken apolipoprotein A-IV.

P. Denéfle, R. Anderson, R. A. Anderson, 2000, Journal of lipid research.

Protective role of interleukin-10 in atherosclerosis.

M. Bureau, V. Deleuze, D. Scherman, 1999, Circulation research.

Apolipoprotein A-I(R151C)Paris is defective in activation of lecithin:cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol efflux

A. von Eckardstein, G. Assmann, P. Cullen, 1999, Journal of Molecular Medicine.

Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice.

J. Auwerx, E. Rubin, A. Guillouzo, 1996, The Journal of clinical investigation.

Systemic Delivery of Murine IL-10 by Intramuscular Injection of Expression Plasmid

V. Deleuze, D. Scherman, M. Bureau, 1999 .

Characterization of human apolipoprotein A-I expressed in Escherichia coli.

E. Rassart, Y. Marcel, P. Denéfle, 1997, Biochimica et biophysica acta.

Human FGF‐1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamsters

B. Schwartz, M. Ivanov, P. Delaère, 2004, The journal of gene medicine.